Immunization for meningococcal serogroup B - What does the practitioner need to know?

Joan L. Robinson; Robert Bortolussi; Natalie A. Bridger; Jane C. Finlay; Susanna Martin; Jane C. McDonald; Heather Onyett; Marina I. Salvadori; Otto G. Vanderkooi; Noni E. MacDonald; Upton D. Allen; Michael Brady; Janet Dollin; Charles P.S. Hui; Nicole Le Saux; Dorothy L. Moore; John S. Spika

doi:10.1093/pch/19.2.91

Immunization for meningococcal serogroup B - What does the practitioner need to know?

Joan L. Robinson, Robert Bortolussi, Natalie A. Bridger, Jane C. Finlay, Susanna Martin, Jane C. McDonald, Heather Onyett, Marina I. Salvadori, Otto G. Vanderkooi, Noni E. MacDonald, Upton D. Allen, Michael Brady, Janet Dollin, Charles P.S. Hui, Nicole Le Saux, Dorothy L. Moore, John S. Spika

Medicine

Résultat de recherche: Article › examen par les pairs

8 Citations (Scopus)

Résumé

Most invasive meningococcal disease in Canada is now caused by serogroup B organisms. A vaccine directed against this serogroup (4CMenB) is newly licensed in Canada. A decision will need to be made by all provinces and territories regarding whether a routine infant immunization program is warranted. This decision will need to take into account factors such as uncertain estimates for the effectiveness of the vaccine, the high incidence of fever from the vaccine and the burden of introducing more injections into the current immunization schedule, and consider them against the potentially preventable mortality and morbidity that result from a rare but very serious disease.

Langue d'origine	English
Pages (de-à)	91-94
Nombre de pages	4
Journal	Paediatrics and Child Health
Volume	19
Numéro de publication	2
DOI	https://doi.org/10.1093/pch/19.2.91
Statut de publication	Published - févr. 2014

ASJC Scopus Subject Areas

Pediatrics, Perinatology, and Child Health

PubMed: MeSH publication types

Journal Article

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1093/pch/19.2.91

Autres fichiers et liens

Citer

Robinson, J. L., Bortolussi, R., Bridger, N. A., Finlay, J. C., Martin, S., McDonald, J. C., Onyett, H., Salvadori, M. I., Vanderkooi, O. G., MacDonald, N. E., Allen, U. D., Brady, M., Dollin, J., Hui, C. P. S., Le Saux, N., Moore, D. L., & Spika, J. S. (2014). Immunization for meningococcal serogroup B - What does the practitioner need to know? Paediatrics and Child Health, 19(2), 91-94. https://doi.org/10.1093/pch/19.2.91

Robinson, JL, Bortolussi, R, Bridger, NA, Finlay, JC, Martin, S, McDonald, JC, Onyett, H, Salvadori, MI, Vanderkooi, OG, MacDonald, NE, Allen, UD, Brady, M, Dollin, J, Hui, CPS, Le Saux, N, Moore, DL & Spika, JS 2014, 'Immunization for meningococcal serogroup B - What does the practitioner need to know?', Paediatrics and Child Health, vol. 19, n° 2, pp. 91-94. https://doi.org/10.1093/pch/19.2.91

@article{973aa521e49d4f8b85a0fb5aae9bd62f,

title = "Immunization for meningococcal serogroup B - What does the practitioner need to know?",

abstract = "Most invasive meningococcal disease in Canada is now caused by serogroup B organisms. A vaccine directed against this serogroup (4CMenB) is newly licensed in Canada. A decision will need to be made by all provinces and territories regarding whether a routine infant immunization program is warranted. This decision will need to take into account factors such as uncertain estimates for the effectiveness of the vaccine, the high incidence of fever from the vaccine and the burden of introducing more injections into the current immunization schedule, and consider them against the potentially preventable mortality and morbidity that result from a rare but very serious disease.",

author = "Robinson, {Joan L.} and Robert Bortolussi and Bridger, {Natalie A.} and Finlay, {Jane C.} and Susanna Martin and McDonald, {Jane C.} and Heather Onyett and Salvadori, {Marina I.} and Vanderkooi, {Otto G.} and MacDonald, {Noni E.} and Allen, {Upton D.} and Michael Brady and Janet Dollin and Hui, {Charles P.S.} and {Le Saux}, Nicole and Moore, {Dorothy L.} and Spika, {John S.}",

year = "2014",

month = feb,

doi = "10.1093/pch/19.2.91",

language = "English",

volume = "19",

pages = "91--94",

journal = "Paediatrics and Child Health",

issn = "1205-7088",